paolo_ceppi Profile Banner
TMC@SDU Profile
TMC@SDU

@paolo_ceppi

Followers
49
Following
17
Media
2
Statuses
24

Our lab is focused on understanding the intricacies of oncogenic metabolic alterations, with focus on therapeutic interventions.

Odense Denmark
Joined February 2020
Don't wanna be here? Send us removal request.
@paolo_ceppi
TMC@SDU
3 years
A new review paper from our lab about targeting mitochondrial metabolism in non-small cell lung cancers, now out in the Drug Resistance Updates journal.
0
0
3
@paolo_ceppi
TMC@SDU
4 years
RT @CellPressNews: Targeting EMT in Cancer with Repurposed Metabolic Inhibitors #TRECANeditorspicks @trendscancer @paolo_ceppi https://t.co….
0
24
0
@paolo_ceppi
TMC@SDU
4 years
RT @NATsdu: Fremtidens kræftmedicin findes måske i lægemidler, der allerede er udviklet. Lad os få dem i spil, for tid betyder alt, mener @….
0
2
0
@paolo_ceppi
TMC@SDU
4 years
Master Thesis opportunities in computational cancer genomics.Start date: Summer 2022.For info please write pceppi@bmb.sdu.dk.Paolo Ceppi, Associate Professor, BMB, University of Southern Denmark
Tweet media one
0
1
4
@paolo_ceppi
TMC@SDU
4 years
We are happy to share our latest publication. Thanks to all those who contributed to this paper.
1
1
14
@paolo_ceppi
TMC@SDU
4 years
RT @FCerrone_UCD: Learnt a lot and got inspired giving my invited virtual talk @europeanmrs Spring 2021 session, thanks to a collaborative….
0
1
0
@paolo_ceppi
TMC@SDU
4 years
RT @bmbSDU: Congratulations to @paolo_ceppi @bmbSDU @NATsdu on receiving a 10m DKK Ascending Investigator Grant from the @novonordiskfond f….
0
2
0
@paolo_ceppi
TMC@SDU
4 years
0
0
0
@paolo_ceppi
TMC@SDU
4 years
I am super happy to annonuce that I have been awarded the 2021 Hallas-Møller Ascending Investigator grant from Novo Nordisk. I am obvioulsy extremely grateful and excited to start the new lung cancer projects. Stay tuned for results!.
researchleaderprogramme.com
Paolo Ceppi says: “Non-small cell lung cancer (NSCLC) is one of the most common and deadliest cancer types. More effective therapeutic strategies based on a better understanding of the mechanisms...
4
1
18
@paolo_ceppi
TMC@SDU
5 years
RT @NATsdu: Stort tillykke til Joo Hyun Park og @Kornfeld_JanW, der netop har modtaget 5m DKK fra Sygeforsikringen Danmark til at forske i….
0
1
0
@paolo_ceppi
TMC@SDU
5 years
RT @NATsdu: Albyler blev lavet til at tage hovedpinen, men kan også forebygge blodpropper. Viagra oprindeligt til hjertekramper, men klarer….
0
1
0
@paolo_ceppi
TMC@SDU
5 years
RT @EbruErbayLab: Pfizer-BioNTech Covid-19 vaccine is 90% effective & uses technology developed by an immuno-oncology company, BioNTech, co….
0
809
0
@paolo_ceppi
TMC@SDU
5 years
RT @BrJCancer: Results from @paolo_ceppi and team establish thymidylate synthase as a theranostic NSCLC marker integrating survival, chemo-….
0
1
0
@paolo_ceppi
TMC@SDU
5 years
Opinion from Ceppi Group at NFZ, University Hospital Erlangen highlighting the potential repurposing of metabolic inhibitors in EMT driven cancers.
Tweet media one
0
2
1
@paolo_ceppi
TMC@SDU
5 years
Recent review accentuating the understated role of pyrimidine metabolism in cancer differentiation.
0
0
2